Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2009 by Rajavithi Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by (Responsible Party):

Rajavithi Hospital

ClinicalTrials.gov Identifier:

NCT01546376

First received: March 2, 2012

Last updated: March 6, 2012

Last verified: January 2009

History of Changes

Tracking Information

First Received Date ^ICMJE

March 2, 2012

Last Updated Date

March 6, 2012

Start Date ^ICMJE

August 2009

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT01546376 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Official Title ^ICMJE

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Brief Summary

Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .

Detailed Description

Not Provided

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Time Perspective: Prospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Non-Probability Sample

Study Population

HIV positive cancer patients Curative RT treatment

Condition ^ICMJE

To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT

Intervention ^ICMJE

Radiation: Radiation therapy
External photon beam radiation therapy dosage 4000-7000 CGy
Other: Venepuncture
Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up

Study Group/Cohort (s)

HIV-cancer patients who recived RT

Interventions:

Radiation: Radiation therapy
Other: Venepuncture

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

100

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Age 18-65 years
HIV positive cancer patients
Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks

Exclusion Criteria:

CD4 count < 200 cell/ml and not received anti retro viral

Gender

Both

Ages

18 Years to 65 Years

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact: Pathomphorn Siraprapasiri, MD

66-89-6662960

spathomphorm@gmail.com

Location Countries ^ICMJE

Thailand

Administrative Information

NCT Number ^ICMJE

NCT01546376

Other Study ID Numbers ^ICMJE

THAIHIV001

Has Data Monitoring Committee

Responsible Party

Rajavithi Hospital

Study Sponsor ^ICMJE

Rajavithi Hospital

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Not Provided

Information Provided By

Rajavithi Hospital

Verification Date

January 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top